FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088889729> ?p ?o ?g. }

• W3088889729 endingPage "581" @default.
• W3088889729 startingPage "573" @default.
• W3088889729 abstract "The human baculoviral IAP repeat containing 5 (BIRC5), also known as survivin, is a conserved member of the inhibitor of apoptosis protein (IAPs) family, which is normally expressed during embryonic and fetal development. Although the expression levels of survivin are low in terminally differentiated cells and/or tissues, they can be found notably increased in certain pathological conditions including malignant tumors. Conventional cloning and sequencing techniques have already confirmed that alternative splicing events of the survivin pre-mRNA result in five distinct alternative transcript variants. In the present study, however, we implemented an innovative, in-house developed, targeted DNA-seq assay to identify novel survivin alternative transcript variants with increased depth and coverage that high-throughput sequencing approaches offer. Bioinformatics analysis of the derived NGS datasets unveiled several novel splice junctions between annotated exons of survivin gene as well as the existence of a novel exon of 117 nt, spanning between the annotated exons 3 and 3B. Validation of the NGS findings with PCR-based assays, using variant-specific primers, led to the identification of fourteen novel survivin alternative splice variants (BIRC5 v.4 - v.17), which demonstrate wide expression profiles in a broad established panel of human cell lines. Although the presented novel findings provide a crystal-clear overview of the survivin mRNAs that are actually generated from the pre-mRNA, future studies should focus on the impending necessity of characterizing the biological function of all novel alternative transcript variants as well as the putative protein isoforms. Such studies will further contribute to our understanding of how the balance between survivin isoforms regulate malignant cell proliferation and apoptosis, providing novel diagnostic, prognostic and predictive biomarkers as well as therapeutic targets." @default.
• W3088889729 created "2020-10-01" @default.
• W3088889729 creator A5003010131 @default.
• W3088889729 creator A5009109774 @default.
• W3088889729 creator A5062927083 @default.
• W3088889729 creator A5085601430 @default.
• W3088889729 date "2021-01-01" @default.
• W3088889729 modified "2023-09-27" @default.
• W3088889729 title "Unraveling novel survivin mRNA transcripts in cancer cells using an in-house developed targeted high-throughput sequencing approach" @default.
• W3088889729 cites W1553241884 @default.
• W3088889729 cites W1662899239 @default.
• W3088889729 cites W1768187423 @default.
• W3088889729 cites W1890390185 @default.
• W3088889729 cites W1971615566 @default.
• W3088889729 cites W1973300532 @default.
• W3088889729 cites W1973916735 @default.
• W3088889729 cites W1992049575 @default.
• W3088889729 cites W1999605095 @default.
• W3088889729 cites W2001742604 @default.
• W3088889729 cites W2003808022 @default.
• W3088889729 cites W2008962264 @default.
• W3088889729 cites W2011920499 @default.
• W3088889729 cites W2015087800 @default.
• W3088889729 cites W2024036230 @default.
• W3088889729 cites W2035523654 @default.
• W3088889729 cites W2042012882 @default.
• W3088889729 cites W2047942169 @default.
• W3088889729 cites W2052523181 @default.
• W3088889729 cites W2053844022 @default.
• W3088889729 cites W2055057101 @default.
• W3088889729 cites W2062230950 @default.
• W3088889729 cites W2064580048 @default.
• W3088889729 cites W2065392301 @default.
• W3088889729 cites W2073013784 @default.
• W3088889729 cites W2075971408 @default.
• W3088889729 cites W2078134389 @default.
• W3088889729 cites W2081936386 @default.
• W3088889729 cites W2083199196 @default.
• W3088889729 cites W2090011952 @default.
• W3088889729 cites W2094985040 @default.
• W3088889729 cites W2102278945 @default.
• W3088889729 cites W2117131162 @default.
• W3088889729 cites W2117582353 @default.
• W3088889729 cites W2117692326 @default.
• W3088889729 cites W2131146282 @default.
• W3088889729 cites W2133735831 @default.
• W3088889729 cites W2134354607 @default.
• W3088889729 cites W2145156967 @default.
• W3088889729 cites W2148583743 @default.
• W3088889729 cites W2151559423 @default.
• W3088889729 cites W2155660862 @default.
• W3088889729 cites W2157408843 @default.
• W3088889729 cites W2157976581 @default.
• W3088889729 cites W2159769705 @default.
• W3088889729 cites W2160743798 @default.
• W3088889729 cites W2161959295 @default.
• W3088889729 cites W2166842799 @default.
• W3088889729 cites W2167490100 @default.
• W3088889729 cites W2219118211 @default.
• W3088889729 cites W2289628124 @default.
• W3088889729 cites W2524270605 @default.
• W3088889729 cites W2561104545 @default.
• W3088889729 cites W2606739316 @default.
• W3088889729 cites W2612976808 @default.
• W3088889729 cites W2753836122 @default.
• W3088889729 cites W2774285006 @default.
• W3088889729 cites W2810881180 @default.
• W3088889729 cites W2896284714 @default.
• W3088889729 cites W2913652149 @default.
• W3088889729 cites W2917207851 @default.
• W3088889729 cites W2925395230 @default.
• W3088889729 cites W2971297443 @default.
• W3088889729 cites W3036441491 @default.
• W3088889729 doi "https://doi.org/10.1016/j.ygeno.2020.09.053" @default.
• W3088889729 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32980523" @default.
• W3088889729 hasPublicationYear "2021" @default.
• W3088889729 type Work @default.
• W3088889729 sameAs 3088889729 @default.
• W3088889729 citedByCount "11" @default.
• W3088889729 countsByYear W30888897292021 @default.
• W3088889729 countsByYear W30888897292022 @default.
• W3088889729 countsByYear W30888897292023 @default.
• W3088889729 crossrefType "journal-article" @default.
• W3088889729 hasAuthorship W3088889729A5003010131 @default.
• W3088889729 hasAuthorship W3088889729A5009109774 @default.
• W3088889729 hasAuthorship W3088889729A5062927083 @default.
• W3088889729 hasAuthorship W3088889729A5085601430 @default.
• W3088889729 hasBestOaLocation W30888897291 @default.
• W3088889729 hasConcept C104317684 @default.
• W3088889729 hasConcept C105580179 @default.
• W3088889729 hasConcept C153911025 @default.
• W3088889729 hasConcept C194583182 @default.
• W3088889729 hasConcept C2775975398 @default.
• W3088889729 hasConcept C36823959 @default.
• W3088889729 hasConcept C53345823 @default.
• W3088889729 hasConcept C54355233 @default.
• W3088889729 hasConcept C54458228 @default.
• W3088889729 hasConcept C67705224 @default.

• next